Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
3 Day Treatment and 8 Week Follow/up	STARTED	Ingenol Mebutate Gel	552
3 Day Treatment and 8 Week Follow/up	STARTED	Vehicle Gel	177
3 Day Treatment and 8 Week Follow/up	COMPLETED	Ingenol Mebutate Gel	541
3 Day Treatment and 8 Week Follow/up	COMPLETED	Vehicle Gel	158
3 Day Treatment and 8 Week Follow/up	NOT COMPLETED	Ingenol Mebutate Gel	11
3 Day Treatment and 8 Week Follow/up	NOT COMPLETED	Vehicle Gel	19
12-month Follow-up	STARTED	Ingenol Mebutate Gel	541
12-month Follow-up	STARTED	Vehicle Gel	157
12-month Follow-up	COMPLETED	Ingenol Mebutate Gel	489
12-month Follow-up	COMPLETED	Vehicle Gel	130
12-month Follow-up	NOT COMPLETED	Ingenol Mebutate Gel	52
12-month Follow-up	NOT COMPLETED	Vehicle Gel	27

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02361216/flow